Author:
Denisenko M. V.,Kurtser M. A.,Kurilo L. F.,Rabadanova A. K.
Publisher
Media Sphere Publishing Group
Subject
Obstetrics and Gynaecology
Reference15 articles.
1. Kavteladze EV, Safronova DA, Solomatina AA, Bratchikova OV. Ovarian reserve and reproductive function in patients after laparoscopic cystectomy for benign ovarian tumors. Vestnik Rossiiskogo gosudarstvennogo meditsinskogo universiteta. 2011;2: 124-127. (In Russ.)
2. Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002;77:3:468-471.
3. Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than folliclestimulating hormone, inhibin B, or estradiol. Fertil Steril. 2004;82:5:1323-1329.
4. Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G. Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod. 2006;21:8: 2022-2026.
5. Massin N, Gougeon A, Meduri G, Thibaud E, Laborde K, Matuchansky C, Constancis E, Vacher-Lavenu MC, Paniel B, Zorn JR, Misrahi M, Kuttenn F, Touraine P. Significance of ovarian histology in the management of patients presenting a premature ovarian failure. Hum Reprod. 2004;19:11:2555-2560.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献